NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report)’s stock price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.71. NovaBay Pharmaceuticals shares last traded at $0.65, with a volume of 231,570 shares changing hands.
NovaBay Pharmaceuticals Price Performance
The firm has a market capitalization of $2.74 million, a PE ratio of -0.07 and a beta of 2.82.
About NovaBay Pharmaceuticals
NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.
Further Reading
- Five stocks we like better than NovaBay Pharmaceuticals
- Find and Profitably Trade Stocks at 52-Week Lows
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Insider Trading – What You Need to Know
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- 3 Tickers Leading a Meme Stock Revival
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
